Home โ€บ Stocks โ€บ RUBICON

Rubicon Research Ltd share price

RUBICON ยท BSE
โ‚น1,679.00โ–ฒ 69.10 (4.29%)
Open
โ‚น1,612.50
Prev close
โ‚น1,609.90
Day high
โ‚น1,704.65
Day low
โ‚น1,612.50
52-wk high
โ‚น1,899.00
52-wk low
โ‚น607.00
See Rubicon Research Ltd live on Traddx Interactive charts, deep fundamentals, peer comparison & your own watchlist โ€” one of 4,800+ NSE & BSE stocks. Free to explore, no card needed.
Open live โ†’
๐Ÿ”” Get a free alert when Rubicon Research Ltd moves Set a price alert, save RUBICON to your watchlist, and unlock the full AI deep dive. Free account โ€” 10 seconds with Google, no password.
Create free account โ†’

Rubicon Research Ltd (RUBICON) is a stock listed on India's exchanges (NSE & BSE). As of the latest filings, Rubicon Research Ltd has a return on equity (ROE) of 27.00%, return on capital employed (ROCE) of 28.40%, a price-to-earnings (P/E) ratio of 96.00 and a debt-to-equity ratio of 0.24. On Traddx you can view its live price, interactive candlestick charts with 20/50/200-day moving averages and golden/death-cross detection, quarterly results, analyst price targets, peer comparison, and the smart-money signal โ€” which star investors hold it and who is buying it on today's bulk/block deals tape.

Key fundamentals

ROE
27.00%
ROCE
28.40%
P/E
96.00
Book value
โ‚น78.10
Dividend yield
0.09%
Debt / equity
0.24
Market cap
โ‚น27,651.00 cr
Face value
โ‚น1.00

Source: screener.in (NSE/BSE filings) ยท Fundamentals as of 02 Nov 2026 ยท figures from the latest annual & quarterly filings. Not investment advice.

See RUBICON live in the app โ†’

Rubicon Research Limited value chain โ€” customers, suppliers & competitors

Rubicon Research Limited is a pharmaceutical company that develops, manufactures, and commercializes differentiated drug formulations, sitting between chemical and raw material suppliers and global healthcare markets.

๐Ÿ›’ Customers โ€” who buys from Rubicon Research Limited

โ›“๏ธ Suppliers โ€” raw materials & inputs

โš”๏ธ Competitors โ€” other sellers

  • Lupin Limited โ€” Competes on global generic formulations and specialized pharma products, with a much larger scale.
  • Sanofi India Limited โ€” Competes on branded and specialized pharmaceutical products in domestic and international markets.

๐Ÿ”€ Other suppliers to its customers

๐Ÿค Peers that share its suppliers

  • Cipla Ltd โ€” Shares common API and chemical raw material suppliers in the Indian pharmaceutical ecosystem.
  • Aurobindo Pharma Ltd โ€” Procures similar chemical inputs and raw materials for generic manufacturing.

This value-chain map is AI-researched from public sources; company links and any figures are estimates, not official company disclosures. Not investment advice.